Development of population and Bayesian models for applied use in patients receiving cefepime
View ORCID ProfileJiajun Liu, View ORCID ProfileMichael Neely, Jeffrey Lipman, Fekade Sime, Jason Roberts, Patrick J Kiel, View ORCID ProfileSean N. Avedissian, View ORCID ProfileNathaniel J. Rhodes, View ORCID ProfileMarc H. Scheetz
doi: https://doi.org/10.1101/19009647
Jiajun Liu
1Midwestern University Chicago College of Pharmacy, Downers Grove, IL USA
2Northwestern Memorial Hospital, Chicago, IL USA
3Midwestern University Chicago College of Pharmacy Pharmacometrics Center of Excellence, Downers Grove, IL USA
Michael Neely
4Children’s Hospital Los Angeles and University of Southern California, Los Angeles, CA
Jeffrey Lipman
5UQ Centre for Clinical Research, Faculty of Medicine, University of Queensland, Australia
6Royal Brisbane and Women’s Hospital, Brisbane, Australia
Fekade Sime
5UQ Centre for Clinical Research, Faculty of Medicine, University of Queensland, Australia
7Centre for Translational Anti-infective Pharmacodynamics, School of Pharmacy, University of Queensland, Australia
Jason Roberts
5UQ Centre for Clinical Research, Faculty of Medicine, University of Queensland, Australia
6Royal Brisbane and Women’s Hospital, Brisbane, Australia
7Centre for Translational Anti-infective Pharmacodynamics, School of Pharmacy, University of Queensland, Australia
Patrick J Kiel
8Indiana University Health, Indianapolis, IN, USA
Sean N. Avedissian
9Antiviral Pharmacology Laboratory, University of Nebraska Medical Center (UNMC) Center for Drug Discovery, UNMC, Omaha, NE USA
10University of Nebraska Medical Center, College of Pharmacy, Omaha, NE USA
Nathaniel J. Rhodes
1Midwestern University Chicago College of Pharmacy, Downers Grove, IL USA
2Northwestern Memorial Hospital, Chicago, IL USA
3Midwestern University Chicago College of Pharmacy Pharmacometrics Center of Excellence, Downers Grove, IL USA
Marc H. Scheetz
1Midwestern University Chicago College of Pharmacy, Downers Grove, IL USA
2Northwestern Memorial Hospital, Chicago, IL USA
3Midwestern University Chicago College of Pharmacy Pharmacometrics Center of Excellence, Downers Grove, IL USA
Data Availability
Data are from primary manuscripts
Posted October 18, 2019.
Development of population and Bayesian models for applied use in patients receiving cefepime
Jiajun Liu, Michael Neely, Jeffrey Lipman, Fekade Sime, Jason Roberts, Patrick J Kiel, Sean N. Avedissian, Nathaniel J. Rhodes, Marc H. Scheetz
medRxiv 19009647; doi: https://doi.org/10.1101/19009647
Subject Area
Subject Areas
- Addiction Medicine (376)
- Allergy and Immunology (691)
- Anesthesia (185)
- Cardiovascular Medicine (2781)
- Dermatology (237)
- Emergency Medicine (418)
- Epidemiology (12432)
- Forensic Medicine (10)
- Gastroenterology (787)
- Genetic and Genomic Medicine (4299)
- Geriatric Medicine (397)
- Health Economics (705)
- Health Informatics (2776)
- Health Policy (1029)
- Hematology (371)
- HIV/AIDS (882)
- Medical Education (406)
- Medical Ethics (113)
- Nephrology (455)
- Neurology (4074)
- Nursing (218)
- Nutrition (603)
- Oncology (2155)
- Ophthalmology (609)
- Orthopedics (252)
- Otolaryngology (313)
- Pain Medicine (257)
- Palliative Medicine (79)
- Pathology (480)
- Pediatrics (1152)
- Primary Care Research (474)
- Public and Global Health (6680)
- Radiology and Imaging (1457)
- Respiratory Medicine (889)
- Rheumatology (425)
- Sports Medicine (354)
- Surgery (467)
- Toxicology (57)
- Transplantation (194)
- Urology (172)